March 19 (Reuters) - EUROFINS SCIENTIFIC SE:
* EUROFINS SCIENTIFIC SUPPORTS HEALTHCARE AUTHORITIES IN EUROPE, THE U.S.A. AND BRAZIL IN THEIR FIGHT AGAINST THE COVID-19 PANDEMIC WITH ADDITIONAL TESTING OPTIONS AND FAST GROWING CAPACITY
* NOW OFFERING TESTING FOR DETECTION OF SARS-COV-2 IN FRANCE, SPAIN AND BRAZIL WITH NETHERLANDS EXPECTED TO START PROCESSING SAMPLES SHORTLY
* NOW EXPECTED TO INCREASE TO WELL OVER 15,000 TESTS PER DAY BY MONDAY 23 MARCH 2020 AND SIGNIFICANTLY MORE BY 01 APRIL 2020
* THIS WEEK, FIVE LABORATORIES STARTED TESTING FOR SARS-COV-2 IN FRANCE.
* ON 11 MARCH 2020, EUROFINS BRAZIL STARTED OFFERING COVID-19 TESTS THROUGH ITS CLINICAL LABORATORY CENTRO DE GENOMAS
* IN GERMANY, EUROFINS MEDIZINISCHES LABOR GELSENKIRCHEN (EUROFINS GELAMED) STARTED TESTING FOR COVID-19 ON 03 MARCH 2020
* IN SPAIN, EUROFINS MEGALAB MADRID ALSO STARTED TESTING FOR COVID-19 THIS WEEK
* GLOBAL CAPACITY CREATED IS CURRENTLY AROUND 10,000 TESTS PER DAY SPLIT ABOUT EQUALLY BETWEEN EUROPE AND AMERICA Source text for Eikon: Further company coverage: (Gdansk Newsroom)
Our Standards: The Thomson Reuters Trust Principles.